DISEASE ACTIVITY ASSESSMENT USING THE DAS28, CDAI AND SDAI AND EFFECT OF ANTI-DRUG ANTIBODY ON CLINICAL RESPONSE IN A RANDOMIZED, DOUBLE-BLIND, COMPARATIVE TRIAL OF CT-P13 AND INNOVATOR INFLIXIMAB: PLANETRA STUDY
Yoo, D. -H.;
Park, W.;
Brzosko, M.;
Geher, P.;
Andersone, D.;
외 6명
제목
DISEASE ACTIVITY ASSESSMENT USING THE DAS28, CDAI AND SDAI AND EFFECT OF ANTI-DRUG ANTIBODY ON CLINICAL RESPONSE IN A RANDOMIZED, DOUBLE-BLIND, COMPARATIVE TRIAL OF CT-P13 AND INNOVATOR INFLIXIMAB: PLANETRA STUDY
저자
Yoo, D. -H.; Park, W.; Brzosko, M.; Geher, P.; Andersone, D.; Jaworski, J.; Rekalov, D.; Oparanov, B.; Kausiene, R.; Pacheco-Tena, C.; Lee, S.